Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida

Novartis in Society Integrated Report 2024

This report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards.

English (PDF 5.0 MB) | German (PDF 4.7 MB)

Prof. Dr. Ulf Landmesser (center) at the Charité hospital in Berlin, Germany

Annual Report 2024 and US Securities & Exchange Commission Form 20-F 2024

These reports provide a comprehensive overview of Novartis, including our company structure, corporate governance, operating and financial results, and compensation practices. They are filed with the SIX Swiss Exchange in Switzerland and the Securities and Exchange Commission in the US.

Annual Report 2024 (PDF 3.5 MB)Form 20-F 2024 (PDF 3.4 MB)